KIDNEY TRANSPLANT

This early-stage trial tests whether a single infusion of stem cells from donated fat tissue can safely treat rejection in kidney transplant recipients. The cells are delivered directly into the kidney artery. The study includes 12 adults with biopsy-proven rejection and aims to …

This study looked at how a tacrolimus tablet (TacroBell) works in people who received a kidney transplant. The goal was to measure drug levels in the blood and see how well patients tolerated it. 128 adults who were getting a kidney from a deceased or living donor took part. The …

This study tested two similar immunosuppressant drugs, MYREPTIC-N® and MY-REPT®, in 158 adults who had a kidney transplant at least a year ago. The goal was to see how well each drug prevented organ rejection, graft loss, or death. Participants continued their usual anti-rejectio…

This study looked at how sitagliptin (Januvia) affects levels of anti-rejection drugs and blood sugar in 16 people who had a kidney transplant and have type 2 diabetes. Participants took sitagliptin daily for 3 months. The goal was to see if it is safe and works well in this grou…

This study tested whether giving monthly fruit and vegetable vouchers to young kidney transplant patients (ages 2-25) who struggle with food insecurity could improve their diet and health. Nineteen participants received an EBT card loaded with funds for six months. Researchers me…

This study looked at 1,819 elderly patients (aged 60+) with end-stage kidney disease to see if getting a living donor kidney transplant that is not a perfect match (ABO- or HLA-incompatible) helps them live longer compared to waiting for a compatible deceased donor. The approach …

This study looked at whether a continuous glucose monitor (CGM) can help track blood sugar levels in 20 people with type 2 diabetes who had a kidney transplant. Participants wore a small sensor that measured glucose around the clock. The goal was to see how often blood sugar stay…

This study compared two types of nerve blocks — erector spinae plane block and transmuscular quadratus lumborum block — for pain after kidney transplant. Forty adults received one of the two blocks with bupivacaine. Researchers measured pain scores and painkiller use over 24 hour…

This study looked at 236 kidney transplant patients to find out why some fail to develop immune protection against cytomegalovirus (CMV) in the first 45 days after surgery. Researchers reviewed medical records to compare patients who had a strong immune response with those who di…

This study tested a smartphone app called Predigraft that helps kidney transplant patients and their doctors monitor the health of the new kidney from home. The app predicts how long the kidney might last and lets patients send in test results and vital signs. The goal was to see…

This study tested a small, handheld device called the Nova Max Pro StatSensor that measures creatinine levels in the blood, a key marker of kidney function. The goal was to see if kidney transplant patients could use it reliably at home, compared to standard lab tests. One hundre…

This study looked at how well the Pfizer COVID-19 vaccine triggers an immune response in 196 adults with weakened immune systems (due to conditions like kidney transplant, cancer, or HIV) compared to healthy adults. Researchers measured antibody levels and their ability to neutra…